|
Home | Technology News Search Engine:
|
|
|
|
Home: Technology News:
|
|
|
(IT-NEWSWIRE.COM, March 30, 2018 ) Browse 87 market data tables and 65 figures spread through 176 pages and in-depth TOC on “PEGylated Proteins Market”
https://www.marketsandmarkets.com/Market-Reports/pegylated-protein-market-19242378.html
Early buyers will receive 10% customization on this report.
This report report provides a detailed overview of the major drivers, restraints, opportunities, and threats impacting the global PEGylated proteins market along with the estimates and forecasts of the revenue and market share analysis.
The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.
The report provides a granular understanding of the market. This report segments the global market on the basis of product, protein type, application, end-user and geography. The product segments included in this report are consumables and services. The consumables segment is further segmented into PEGylation reagents, and PEGylation kits. The consumables segment accounts for the largest share of the global market in 2016 owing to the increasing adoption of kit-based PEGylation products.
Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=19242378
The protein type segment includes colony stimulating factors, interferons, erythropoietin, mAbs, and recombinant factor VIII. The colony stimulating factors segment is expected to grow at the highest rate among the protein type segments, owing to the increasing incidence of cancer across the globe and also to enhance the chemotherapy process.
The application segment is segmented into cancer treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis, and gastrointestinal disorders. The end-user segments included in this report are pharmaceutical & biotechnology companies, CROs, and academic research institutes.
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The report maps each product, protein type, application and end-user segment in 6 geographic and regional segments. Geographic analysis reveals that North America accounted for the largest share of the global PEGylated proteins market in 2016.
Growth in this market can be attributed to the increased adoption of biologics drugs such as monoclonal antibodies, erythropoietin and interferon for the treatment of chronic diseases; increasing government funding and grants for research activities, and increasing R&D spending for drug discovery at early stages. Similarly Asia is estimated to be the fastest growing market of the global market in 2016.
The wide applications of PEGylated proteins in treating cancer, blood disorder, chronic and autoimmune disease are expected to drive the demand for market in this region.
Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=19242378
The major players in this market include Merck Millipore (U.S.), Thermo Fisher Scientific, Inc. (U.S.), NOF Corporation (Japan), JenKem Technology USA, Inc. (U.S.), Creative PEGworks (U.S), Celares GmbH (Germany), Quanta BioDesign, Ltd. (U.S.), Biomatrik, Inc, (China), Iris Biotech GmbH (Germany), Laysan Bio, Ltd. (U.S.).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
Technology News Headlines
|
|
|
|
|
Technology Business Video Feed
|
|
More Technology Video Feeds
|
|
|
